We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Contribute to Expert Opinion on Orphan Drugs

Expert Opinion on Orphan Drugs is welcoming submission on the following:

  • Reviews that focus on rare diseases or orphan drugs, and report on any of the following topics: diagnostics, pharmacogenomics and screening; prevalence and epidemiology (with particular attention to regional variations); drug development; lead generation and discovery; early or late phase clinical trials; regulatory issues; post-marketing safety; treatment outcomes.
  • Drug Evaluations specifically reviewing the pharmacological properties; clinical potential/clinical efficacy; safety and, if applicable, HE/OR data on a particular orphan drug.
  • Original Research papers reporting the results of early or late stage clinical investigations or HE/OR data on orphan drugs and studies in the treatment of rare diseases.
  • Editorials, commentaries and meeting-highlights papers covering topics in rare diseases.

Expert Opinion on Orphan Drugs

Expert Opinion on Orphan Drugs is an international, peer-reviewed journal that covers all aspects of R&D on rare diseases and orphan drugs.

Visit Journal Articles

What does Expert Opinion on Orphan Drugs offer it's authors?

  • Wide readership in an international journal with an 2018 Impact Factor of 0.763*
  • Free standard submission, or the option to publish FastTrack and RapidTrack with our Accelerated Publication services
  • Share your research with 50 free e-prints and tips on promoting your article courtesy of our Author Resources site
  • Immediately see the impact your research made in the community: track downloads, citations, and the Altmetric Score of your article on My Authored Works

*© 2018 Journal Citation Reports® (Clarivate Analytics, 2019)

Submission guidelines

Review our Instructions for Authors site to ensure you have everything required to move through peer review, production and publication.

When you are ready, you can submit through our online submission system.

To view our current issue please visit our homepage. If you would like to submit an article or have any questions about the journal please contact the journal's Commissioning Editor Mithi Ahmed.

Submit your Manuscript

Read these articles for free until December 31st 2019

Article TitleAuthor(s)VolumeIssue
Autoimmune hemolytic anemia - progress in emerging treatment options
Wilma Barcellini & Bruno Fattizzo64
Emerging and potential treatment options for sarcoidosis
Debabrata Bandyopadhyay & Marc A. Judson61
Emerging therapeutics for the treatment of Friedreich’s ataxia
Elisabetta Indelicato & Sylvia Bösch61
An update on emerging therapeutic options for the treatment of trigeminal neuralgia
Mark Obermann, Zaza Katsarava & Dagny Holle511
Imetelstat for treatment of myelofibrosis
E. Virtgaym, D. Tremblay, C. Iancu-Rubin, R. Hoffman & J. Mascarenhas51
Advances in new drug therapies for the management of sickle cell disease
Kenneth I. Ataga & Payal C. Desai65
Advances in the understanding of hereditary ataxia – implications for future patients
Anna Zeitlberger, Heather Ging, Suran Nethisinghe & Paola Giunti63
Gene therapy for the treatment of adenosine deaminase-deficient severe combined immune deficiency
Robert Sokolic & Fabio Candotti56
Limb girdle muscular dystrophies: clinical-genetical diagnostic update and prospects for therapy
Corrado Angelini & Marina Fanin510
Genetic therapy of Xeroderma Pigmentosum: analysis of strategies and translation
Maria Goncalves-Maia & Thierry Magnaldo51

Latest Tweets